Buchang Pharmaceutical announced that Baoding Tianhao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for terbinafine hydrochloride spray approved and issued by the State Drug Administration. The drug is a Class 4 class A non-prescription drug used to treat hand tinea, foot tinea, tinea cruris, tinea versicolor, etc. As of July 31, 2026, the company invested about 2.445,800 yuan in R&D expenses on this drug project. This certification helps the company optimize its product structure and has a positive impact on future operations.

Buchang Pharmaceutical announced that Baoding Tianhao Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for terbinafine hydrochloride spray approved and issued by the State Drug Administration. The drug is a Class 4 class A non-prescription drug used to treat hand tinea, foot tinea, tinea cruris, tinea versicolor, etc. As of July 31, 2026, the company invested about 2.445,800 yuan in R&D expenses on this drug project. This certification helps the company optimize its product structure and has a positive impact on future operations.